← Leaderboards
Mengcheng Shen
Stanford University
$505,985
Attributed
$505,985
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2023–25$250K$187.5K$125K$62.5K$0
'23
'24
'25
Funding mix
By agency
NIH$505,985 · 2
By mechanism
K99$256,986 · 1
R00$248,999 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Thomas None Quertermous$63,279,401
- Gavin J Sherlock$42,559,674
- Michael L Whitfield$14,056,386
- Utkan Demirci$14,678,583
- Marlene Rabinovitch$40,032,014
Others in their field
Other Rising Stars on “Advisory Committees”
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Johanna Marizan-Ho · Palantir Technologies, Inc.$9,612,691
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Brian Todd Schaneberg · Illinois Institute Of Technology$6,784,113
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
- Christine O'Connell · H. Lee Moffitt Cancer Ctr & Res Inst$5,494,823
Research focus
Advisory CommitteesAgonistAngiogenesis InhibitorsAnimal ModelAntagonistApoptosisBasic ScienceBiological MarkersBiological ModelsBiologyBiomedical EngineeringBlood PerfusionBlood VesselsCancer PatientCancer SurvivorCancer TherapyCandidate Disease GeneCardiacCardiovascular DiseasesCardiovascular SystemCareerCareer DevelopmentCell Communication3-Dimensional
Grant awards (3)
Elucidating anti-angiogenic tyrosine kinase inhibitor-induced vascular dysfunction$248,999
R00 · FY2025 · HL · contact PI
Elucidating anti-angiogenic tyrosine kinase inhibitor-induced vascular dysfunction$128,493
K99 · FY2024 · HL · contact PI
Elucidating anti-angiogenic tyrosine kinase inhibitor-induced vascular dysfunction$128,493
K99 · FY2023 · HL · contact PI